Réirradiations des carcinomes épidermoïdes des voies aérodigestives supérieures : indications et résultats
暂无分享,去创建一个
Pierre Blanchard | J. Biau | M. Lapeyre | J. Thariat | Juliette Thariat | J. Biau | J. Moreau | J. Miroir | M. Lapeyre | P. Blanchard | J. Moreau | J. Miroir | Julian Biau | Michel Lapeyre
[1] J. Cygler,et al. Interstitial low‐dose‐rate brachytherapy in the treatment of recurrent head and neck malignancies , 2006, Head & neck.
[2] D. Heron,et al. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. , 2015, International journal of radiation oncology, biology, physics.
[3] Pascal Haigron,et al. Evaluation of Deformable Image Registration Methods for Dose Monitoring in Head and Neck Radiotherapy , 2015, BioMed research international.
[4] G. Calais,et al. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] D. Heron,et al. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. , 2017, International journal of radiation oncology, biology, physics.
[6] M. Machtay,et al. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A Kramar,et al. Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] E. Yorke,et al. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group. , 2018, International journal of radiation oncology, biology, physics.
[9] A. Sanabria,et al. Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature. , 2019, Critical reviews in oncology/hematology.
[10] A. Bozec,et al. Réirradiation des cancers des voies aérodigestives supérieures , 2017 .
[11] J. Mazeron,et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. , 1987, International journal of radiation oncology, biology, physics.
[12] D. Heron,et al. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. , 2017, International journal of radiation oncology, biology, physics.
[13] P. Frankel,et al. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. , 2005, International journal of radiation oncology, biology, physics.
[14] J. Biau,et al. Brachytherapy after salvage surgery in cases with large isolated cervical recurrence of squamous cell carcinoma in the previously irradiated neck , 2016, Head & neck.
[15] J. Flickinger,et al. A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer , 2012, Head & neck oncology.
[16] R. Stupp,et al. Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer. , 1995, Seminars in oncology.
[17] A. Taghian,et al. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin. , 1988, International journal of radiation oncology, biology, physics.
[18] D. Heron,et al. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. , 2017, Future oncology.
[19] P. Catalano,et al. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences. , 2016, Oral oncology.
[20] K. Ang,et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Biau,et al. [Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases]. , 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[22] V. Grégoire,et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. de Bree,et al. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma , 2006, Cancer.
[24] E. Genden,et al. The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma , 2018, Cancers.
[25] J. Phan,et al. Reirradiation of head and neck cancer using modern highly conformal techniques , 2018, Head & neck.
[26] J. Bourhis,et al. Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas—Stratification for postsalvage survival , 2009, Head & neck.
[27] Y. Lupiáñez-Pérez,et al. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence. , 2017, Critical reviews in oncology/hematology.
[28] S Nag,et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[29] D. Peiffert,et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. , 1994, International journal of radiation oncology, biology, physics.
[30] V. Grégoire,et al. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. , 2018, Oral oncology.
[31] Yi-Jen Chen,et al. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. , 2001, International journal of radiation oncology, biology, physics.
[32] D. Heron,et al. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. , 2017, International journal of radiation oncology, biology, physics.
[33] P. Levendag,et al. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] N. Lee,et al. Proton Therapy for Head and Neck Cancers. , 2018, Seminars in radiation oncology.
[35] N. Lee,et al. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? , 2011, International journal of radiation oncology, biology, physics.
[36] D. Heron,et al. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. , 2016, International journal of radiation oncology, biology, physics.
[37] S. Spencer,et al. Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck , 2008, Head & neck.
[38] P. Bondiau,et al. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] D. Heron,et al. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: Implications of treatment duration and tumor volume , 2014, Head & neck.
[40] J. Bourhis,et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma , 2001, Cancer.
[41] J. Pignon,et al. Individual patients' data meta-analyses in head and neck cancer , 2007, Current opinion in oncology.
[42] D. Heron,et al. Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck cancer , 2014, The Laryngoscope.
[43] Y. Soon,et al. Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis , 2018, Head & neck.
[44] A. Eisbruch,et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. , 2009, International journal of radiation oncology, biology, physics.
[45] J. Thariat,et al. Réirradiation des tumeurs de la tête et du cou : volumes cibles, évolutions techniques et perspectives , 2018 .